Kristy L Richards

6PUBLICATIONS
26CO-AUTHORS
Haematological tumoursLiquid biopsiesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 13, 2018
Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma.

Marissa L Cann, Laura E Herring, Lauren L Haar

|Jul 04, 2018
Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations.

Sarah C Rutherford, Angela A Fachel, Sheng Li

|Apr 21, 2017
Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.

Andrea B Moffitt, Sarah L Ondrejka, Matthew McKinney

|Nov 07, 2015
Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Zijun Y Xu-Monette, Bouthaina S Dabaja, Xiaoxiao Wang

|Aug 08, 2015
Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy.

Zhiyu Liu, Zijun Y Xu-Monette, Xin Cao

|Jun 27, 2015
Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.

Chi Young Ok, Zijun Y Xu-Monette, Ling Li

Pageof 1

Frequent Collaborators

3 joint publications

Govind Bhagat

2 joint publications

Santiago Montes-Moreno

1 joint publications

Chi Young Ok

1 joint publications

Alexandar Tzankov